• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带自杀基因的人类干细胞提高了帕金森病大鼠神经移植的安全性和标准化。

Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in Parkinsonian rats.

机构信息

The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.

Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia.

出版信息

Nat Commun. 2021 May 27;12(1):3275. doi: 10.1038/s41467-021-23125-9.

DOI:10.1038/s41467-021-23125-9
PMID:34045451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8160354/
Abstract

Despite advancements in human pluripotent stem cells (hPSCs) differentiation protocols to generate appropriate neuronal progenitors suitable for transplantation in Parkinson's disease, resultant grafts contain low proportions of dopamine neurons. Added to this is the tumorigenic risk associated with the potential presence of incompletely patterned, proliferative cells within grafts. Here, we utilised a hPSC line carrying a FailSafe suicide gene (thymidine kinase linked to cyclinD1) to selectively ablate proliferative cells in order to improve safety and purity of neural transplantation in a Parkinsonian model. The engineered FailSafe hPSCs demonstrated robust ventral midbrain specification in vitro, capable of forming neural grafts upon transplantation. Activation of the suicide gene within weeks after transplantation, by ganciclovir administration, resulted in significantly smaller grafts without affecting the total yield of dopamine neurons, their capacity to innervate the host brain or reverse motor deficits at six months in a rat Parkinsonian model. Within ganciclovir-treated grafts, other neuronal, glial and non-neural populations (including proliferative cells), were significantly reduced-cell types that may pose adverse or unknown influences on graft and host function. These findings demonstrate the capacity of a suicide gene-based system to improve both the standardisation and safety of hPSC-derived grafts in a rat model of Parkinsonism.

摘要

尽管人类多能干细胞(hPSCs)分化方案在生成适合帕金森病移植的适当神经元祖细胞方面取得了进展,但产生的移植物中多巴胺神经元的比例仍然较低。此外,移植物中存在未完全定型、增殖细胞的致瘤风险也增加了这一问题。在这里,我们利用携带失效安全自杀基因(与细胞周期蛋白 D1 相连的胸苷激酶)的 hPSC 系,选择性地消除增殖细胞,以提高帕金森病模型中神经移植的安全性和纯度。工程化的失效安全 hPSC 在体外表现出强大的中脑神经节特异性,能够在移植后形成神经移植物。在移植后数周内通过给予更昔洛韦激活自杀基因,导致移植物明显缩小,而不影响多巴胺神经元的总产量、它们对宿主大脑的支配能力或在帕金森病大鼠模型中六个月时的运动缺陷的逆转。在更昔洛韦处理的移植物中,其他神经元、神经胶质和非神经元群体(包括增殖细胞)明显减少——这些细胞类型可能对移植物和宿主功能产生不良或未知的影响。这些发现证明了基于自杀基因的系统在帕金森病大鼠模型中改善 hPSC 衍生移植物的标准化和安全性的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/5969f621167e/41467_2021_23125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/99de81321525/41467_2021_23125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/85a16f1380ed/41467_2021_23125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/8ad070e29121/41467_2021_23125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/5969f621167e/41467_2021_23125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/99de81321525/41467_2021_23125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/85a16f1380ed/41467_2021_23125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/8ad070e29121/41467_2021_23125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff45/8160354/5969f621167e/41467_2021_23125_Fig4_HTML.jpg

相似文献

1
Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in Parkinsonian rats.携带自杀基因的人类干细胞提高了帕金森病大鼠神经移植的安全性和标准化。
Nat Commun. 2021 May 27;12(1):3275. doi: 10.1038/s41467-021-23125-9.
2
Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.LMX1a 腹侧中脑神经祖细胞的分离提高了人多能干细胞源性神经移植在帕金森病中的安全性和可预测性。
J Neurosci. 2019 Nov 27;39(48):9521-9531. doi: 10.1523/JNEUROSCI.1160-19.2019. Epub 2019 Oct 22.
3
Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.鉴定人类多能干细胞衍生的中脑多巴胺能祖细胞在帕金森病啮齿动物模型中移植的最佳发育年龄。
Exp Neurol. 2022 Dec;358:114219. doi: 10.1016/j.expneurol.2022.114219. Epub 2022 Aug 30.
4
Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.早期发育标志物的表达预测胚胎干细胞向中脑多巴胺能神经元分化的效率。
Stem Cells Dev. 2013 Feb 1;22(3):397-411. doi: 10.1089/scd.2012.0238. Epub 2012 Sep 20.
5
Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.胎儿人类中脑神经祖细胞系的临床前分析:体外和体内鉴定和安全性。
Stem Cells Transl Med. 2017 Feb;6(2):576-588. doi: 10.5966/sctm.2015-0228. Epub 2016 Sep 2.
6
Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.无饲养层条件下人多能干细胞来源的高效特化腹侧中脑多巴胺神经元可恢复帕金森病模型鼠的运动障碍。
Stem Cells Transl Med. 2017 Mar;6(3):937-948. doi: 10.5966/sctm.2016-0073. Epub 2016 Oct 14.
7
Meningeal cells influence midbrain development and the engraftment of dopamine progenitors in Parkinsonian mice.脑膜细胞影响帕金森病小鼠的中脑发育和多巴胺祖细胞的植入。
Exp Neurol. 2015 May;267:30-41. doi: 10.1016/j.expneurol.2015.02.017. Epub 2015 Feb 20.
8
Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.在帕金森病的6-羟基多巴胺大鼠模型中进行人神经嵴衍生神经元的纹状体内和黑质内移植。
Exp Neurol. 2000 Apr;162(2):350-60. doi: 10.1006/exnr.1999.7337.
9
Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats.移植到帕金森病大鼠中脑的 hESC 衍生多巴胺神经元的靶向性前脑投射和适当的突触输入。
J Comp Neurol. 2018 Sep 1;526(13):2133-2146. doi: 10.1002/cne.24500. Epub 2018 Jul 31.
10
Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).人神经干细胞诱导分化的功能性多巴胺能神经元在大鼠 6-OH-DA 帕金森病模型中长期的行为学效应。BCL-X(L)强制表达的影响。
Behav Brain Res. 2012 Jun 15;232(1):225-32. doi: 10.1016/j.bbr.2012.04.020. Epub 2012 Apr 17.

引用本文的文献

1
Research progress of cell treatment strategy in Parkinson's disease.帕金森病细胞治疗策略的研究进展
Neurosci Appl. 2024 Mar 30;3:104061. doi: 10.1016/j.nsa.2024.104061. eCollection 2024.
2
Exercise promotes the functional integration of human stem cell-derived neural grafts in a rodent model of Parkinson's disease.运动促进人干细胞衍生神经移植物在帕金森病啮齿动物模型中的功能整合。
Stem Cell Reports. 2025 May 13;20(5):102480. doi: 10.1016/j.stemcr.2025.102480. Epub 2025 Apr 24.
3
Somatic cell reprogramming for Parkinson's disease treatment.

本文引用的文献

1
An Optimized Protocol for the Generation of Midbrain Dopamine Neurons under Defined Conditions.在定义条件下生成中脑细胞多巴胺神经元的优化方案。
STAR Protoc. 2020 Jul 15;1(2):100065. doi: 10.1016/j.xpro.2020.100065. eCollection 2020 Sep 18.
2
Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's disease.单细胞转录组学鉴定帕金森病模型中干细胞衍生移植物的组成。
Nat Commun. 2020 May 15;11(1):2434. doi: 10.1038/s41467-020-16225-5.
3
Viral Delivery of GDNF Promotes Functional Integration of Human Stem Cell Grafts in Parkinson's Disease.
用于帕金森病治疗的体细胞重编程
Ibrain. 2025 Jan 4;11(1):59-73. doi: 10.1002/ibra.12189. eCollection 2025 Spring.
4
Advances in clinical translation of stem cell-based therapy in neurological diseases.基于干细胞的疗法在神经疾病临床转化方面的进展。
J Cereb Blood Flow Metab. 2025 Apr;45(4):600-616. doi: 10.1177/0271678X251317374. Epub 2025 Jan 30.
5
Microfluidic chip systems for characterizing glucose-responsive insulin-secreting cells equipped with FailSafe kill-switch.配备故障安全自毁开关的用于表征葡萄糖响应性胰岛素分泌细胞的微流控芯片系统。
Stem Cell Res Ther. 2024 Dec 18;15(1):486. doi: 10.1186/s13287-024-04059-7.
6
A systematic review of progenitor survival and maturation in Parkinsonian models.帕金森病模型中祖细胞存活与成熟的系统评价。
Neural Regen Res. 2025 Nov 1;20(11):3172-3178. doi: 10.4103/NRR.NRR-D-24-00894. Epub 2024 Nov 13.
7
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.将线粒体生物学融入神经退行性疾病的创新细胞疗法
Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899.
8
Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes.多能干细胞衍生的心肌细胞修复心脏的挑战与展望。
Nat Cardiovasc Res. 2024 May;3(5):515-524. doi: 10.1038/s44161-024-00472-6. Epub 2024 May 14.
9
iPS cell generation-associated point mutations include many C > T substitutions via different cytosine modification mechanisms.iPS 细胞生成相关点突变包括许多通过不同胞嘧啶修饰机制的 C>T 取代。
Nat Commun. 2024 Jun 11;15(1):4946. doi: 10.1038/s41467-024-49335-5.
10
Cell reprogramming therapy for Parkinson's disease.帕金森病的细胞重编程疗法
Neural Regen Res. 2024 Nov 1;19(11):2444-2455. doi: 10.4103/1673-5374.390965. Epub 2023 Dec 15.
病毒递送 GDNF 促进人干细胞移植物在帕金森病中的功能整合。
Cell Stem Cell. 2020 Apr 2;26(4):511-526.e5. doi: 10.1016/j.stem.2020.01.010. Epub 2020 Feb 13.
4
Transcriptional Profiling of Xenogeneic Transplants: Examining Human Pluripotent Stem Cell-Derived Grafts in the Rodent Brain.异种移植的转录组学分析:在啮齿动物大脑中研究人类多能干细胞衍生移植物。
Stem Cell Reports. 2019 Nov 12;13(5):877-890. doi: 10.1016/j.stemcr.2019.10.001. Epub 2019 Oct 31.
5
Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.LMX1a 腹侧中脑神经祖细胞的分离提高了人多能干细胞源性神经移植在帕金森病中的安全性和可预测性。
J Neurosci. 2019 Nov 27;39(48):9521-9531. doi: 10.1523/JNEUROSCI.1160-19.2019. Epub 2019 Oct 22.
6
Linking a cell-division gene and a suicide gene to define and improve cell therapy safety.将细胞分裂基因和自杀基因连接起来,以定义和提高细胞治疗的安全性。
Nature. 2018 Nov;563(7733):701-704. doi: 10.1038/s41586-018-0733-7. Epub 2018 Nov 14.
7
IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.基于内体相关蛋白分选的方法得到均一的人多能干细胞源性多巴胺能前体细胞用于移植。
Stem Cell Reports. 2017 Oct 10;9(4):1207-1220. doi: 10.1016/j.stemcr.2017.08.016. Epub 2017 Sep 21.
8
A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.人胚胎干细胞来源移植体中多巴胺和非多巴胺神经元亚型连接性的 PITX3-EGFP 报告系揭示
Stem Cell Reports. 2017 Sep 12;9(3):868-882. doi: 10.1016/j.stemcr.2017.08.002. Epub 2017 Aug 31.
9
Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.将干细胞衍生的多巴胺神经元应用于临床的策略——纽约干细胞科学计划(NYSTEM)试验
Prog Brain Res. 2017;230:191-212. doi: 10.1016/bs.pbr.2017.02.008. Epub 2017 Mar 21.
10
Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).将干细胞衍生的多巴胺神经元应用于临床的策略:一种欧洲方法(STEM-PD)。
Prog Brain Res. 2017;230:165-190. doi: 10.1016/bs.pbr.2016.11.011. Epub 2017 Feb 7.